Literature DB >> 23689970

The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.

Anu Jacob1, Jay Panicker, Daniel Lythgoe, Liene Elsone, Kerry Mutch, Martin Wilson, Kumar Das, Mike Boggild.   

Abstract

Neuromyelitis optica (NMO) is an uncommon, demyelinating disease that causes long-term disability in adults. Though much has recently been learned about its pathogenesis, there are still only a few studies regarding the epidemiology of NMO. The aim of the study was to describe the epidemiology of NMO among adults in the Merseyside county of the United kingdom. Multiple overlapping sources of data were used including hospital records of The Walton Centre for Neurology and Neurosurgery in Liverpool, regional district general hospital data, central Aquaporin-4 antibody testing laboratory data and the British Neurological Surveillance Unit- to identify adults with a first-ever-in-a-lifetime diagnosis of NMO. As of December 31, 2010, there were eight cases (five NMO; three NMO spectrum disorder), indicating a prevalence of 7.2/million (95 % CI 3.1-14.2). Four incident cases of NMO and three incident cases of NMO spectrum disorder were identified in this period, indicating a minimum combined average annual incidence rate of 0.8/million (95 % CI 0.3-1.6). NMO still remains an uncommon condition, but the prevalence is rising with early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689970     DOI: 10.1007/s00415-013-6926-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  MS and neuromyelitis optica in Martinique (French West Indies).

Authors:  P Cabre; O Heinzlef; H Merle; G G Buisson; O Bera; R Bellance; J C Vernant; D Smadja
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  An epidemiological study of neuromyelitis optica in Cuba.

Authors:  Jose A Cabrera-Gómez; John F Kurtzke; Alina González-Quevedo; R Lara-Rodríguez
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

3.  The British Neurological Surveillance Unit: a nation-wide scheme for the ascertainment of rare neurological disorders.

Authors:  O C Cockerell; S Gupta; M Catchpole; J W Sander; S D Shorvon
Journal:  Neuroepidemiology       Date:  1995       Impact factor: 3.282

4.  Prevalence of multiple sclerosis in Rochdale.

Authors:  D I Shepherd; A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  The prevalence of neuromyelitis optica in South East Wales.

Authors:  M Cossburn; G Tackley; K Baker; G Ingram; M Burtonwood; G Malik; T Pickersgill; J te Water Naudé; N Robertson
Journal:  Eur J Neurol       Date:  2011-10-04       Impact factor: 6.089

6.  A population-based study of neuromyelitis optica in Caucasians.

Authors:  N Asgari; S T Lillevang; H P B Skejoe; M Falah; E Stenager; K O Kyvik
Journal:  Neurology       Date:  2011-05-03       Impact factor: 9.910

7.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

8.  Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases.

Authors:  Y Kuroiwa; A Igata; K Itahara; S Koshijima; T Tsubaki
Journal:  Neurology       Date:  1975-09       Impact factor: 9.910

  8 in total
  27 in total

Review 1.  Neuro-ophthalmology update.

Authors:  Konrad P Weber; Dominik Straumann
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

2.  Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.

Authors:  Sabrina Gmuca; Duriel I Hardy; Sona Narula; Sharon Stoll; Julia Harris; Yongdong Zhao; Rui Xiao; Pamela F Weiss; Amy T Waldman; Jeffrey S Gerber
Journal:  Mult Scler Relat Disord       Date:  2019-11-01       Impact factor: 4.339

3.  Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

Authors:  Sara Salama; Hazem Marouf; M Ihab Reda; Amal R Mansour; Osama ELKholy; Michael Levy
Journal:  J Neuroimmunol       Date:  2018-08-29       Impact factor: 3.478

4.  The clinical profile of NMOSD in Australia and New Zealand.

Authors:  Wajih Bukhari; Laura Clarke; Cullen O'Gorman; Elham Khalilidehkordi; Simon Arnett; Kerri M Prain; Mark Woodhall; Roger Silvestrini; Christine S Bundell; Sudarshini Ramanathan; David Abernethy; Sandeep Bhuta; Stefan Blum; Mike Boggild; Karyn Boundy; Bruce J Brew; Wallace Brownlee; Helmut Butzkueven; William M Carroll; Celia Chen; Alan Coulthard; Russell C Dale; Chandi Das; Keith Dear; Marzena J Fabis-Pedrini; David Fulcher; David Gillis; Simon Hawke; Robert Heard; Andrew P D Henderson; Saman Heshmat; Suzanne Hodgkinson; Sofia Jimenez-Sanchez; Trevor J Kilpatrick; John King; Chris Kneebone; Andrew J Kornberg; Jeannette Lechner-Scott; Ming-Wei Lin; Christopher Lynch; Richard A L Macdonnell; Deborah F Mason; Pamela A McCombe; Jennifer Pereira; John D Pollard; Stephen W Reddel; Cameron Shaw; Judith Spies; James Stankovich; Ian Sutton; Steve Vucic; Michael Walsh; Richard C Wong; Eppie M Yiu; Michael H Barnett; Allan G Kermode; Mark P Marriott; John Parratt; Mark Slee; Bruce V Taylor; Ernest Willoughby; Robert J Wilson; Fabienne Brilot; Angela Vincent; Patrick Waters; Simon A Broadley
Journal:  J Neurol       Date:  2020-01-31       Impact factor: 4.849

5.  Differential diagnoses to MS: experiences from an optic neuritis clinic.

Authors:  Henrik Horwitz; Tina Friis; Signe Modvig; Hanne Roed; Anna Tsakiri; Bjarne Laursen; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

6.  Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Authors:  Eoin P Flanagan; Philippe Cabre; Brian G Weinshenker; Jennifer St Sauver; Debra J Jacobson; Masoud Majed; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Marcelo Matiello; Nilifur Kale; Dean M Wingerchuk; Jay Mandrekar; Jessica A Sagen; James P Fryer; Angala Borders Robinson; Sean J Pittock
Journal:  Ann Neurol       Date:  2016-04-04       Impact factor: 10.422

Review 7.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 8.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

Review 9.  Demographic and clinical features of neuromyelitis optica: A review.

Authors:  L Pandit; N Asgari; M Apiwattanakul; J Palace; F Paul; M I Leite; I Kleiter; T Chitnis
Journal:  Mult Scler       Date:  2015-04-28       Impact factor: 6.312

10.  Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.

Authors:  Regina Maria Papais-Alvarenga; Claudia Cristina Ferreira Vasconcelos; Adriana Carra; Ibis Soto de Castillo; Sara Florentin; Fernando Hamuy Diaz de Bedoya; Raul Mandler; Luiza Campanella de Siervi; Maria Lúcia Vellutini Pimentel; Marina Papais Alvarenga; Marcos Papais Alvarenga; Anderson Kuntz Grzesiuk; Ana Beatriz Calmon Gama Pereira; Antonio Pereira Gomes Neto; Carolina Velasquez; Carlos Soublette; Cynthia Veronica Fleitas; Denise Sisteroli Diniz; Elizabeth Armas; Elizabeth Batista; Freda Hernandez; Fernanda Ferreira Chaves da Costa Pereira; Heloise Helena Siqueira; Hideraldo Cabeça; Jose Sanchez; Joseph Bruno Bidin Brooks; Marcus Vinicius Gonçalves; Maria Cristina Del Negro Barroso; Maria Elena Ravelo; Maria Carlota Castillo; Maria Lúcia Brito Ferreira; Maria Sheila Guimarães Rocha; Monica Koncke Fiuza Parolin; Omaira Molina; Patricia Beatriz Christino Marinho; Paulo Pereira Christo; Renata Brant de Souza; Silvio Pessanha Neto; Solange Maria das Graças Camargo; Suzana Costa Machado; Vanderson Carvalho Neri; Yara Dadalti Fragoso; Helcio Alvarenga; Luiz Claudio Santos Thuler
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.